Censo Biotechnologies Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 38

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 7

Censo Biotechnologies General Information

Description

Provider of iPSC discovery services intended to support neurodegenerative, neuro-inflammation and rare disease-focused research. The company's services involve editing genes along the human iPSC lines to knock in, knock out or correct target genes of interest using CRISPR in order to develop reproducible differentiation protocols for a number of lineages, providing a diverse range of existing human iPSC lines and ethically sources relevant human tissue, enabling biotech organizations to use these cells for conducting research related to the development of drugs for tackling neurodegenerative and neuro-inflammatory diseases.

Contact Information

Formerly Known As
Roslin Cellab
Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • Charnock Bradley Building
  • Easter Bush
  • Roslin EH25 9RG
  • Scotland, United Kingdom
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Discovery Tools (Healthcare)
Acquirer
Vertical(s)
Corporate Office
  • Charnock Bradley Building
  • Easter Bush
  • Roslin EH25 9RG
  • Scotland, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Censo Biotechnologies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Censo Biotechnologies‘s full profile, request access.

Request a free trial

Censo Biotechnologies Patents

Censo Biotechnologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202005290-D0 Microphage Inactive 09-Apr-2020

Censo Biotechnologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Censo Biotechnologies Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Censo Biotechnologies‘s full profile, request access.

Request a free trial

Censo Biotechnologies FAQs

  • When was Censo Biotechnologies founded?

    Censo Biotechnologies was founded in 2009.

  • Where is Censo Biotechnologies headquartered?

    Censo Biotechnologies is headquartered in Roslin, United Kingdom.

  • What is the size of Censo Biotechnologies?

    Censo Biotechnologies has 38 total employees.

  • What industry is Censo Biotechnologies in?

    Censo Biotechnologies’s primary industry is Biotechnology.

  • Is Censo Biotechnologies a private or public company?

    Censo Biotechnologies is a Private company.

  • What is the current valuation of Censo Biotechnologies?

    The current valuation of Censo Biotechnologies is .

  • What is Censo Biotechnologies’s current revenue?

    The current revenue for Censo Biotechnologies is .

  • How much funding has Censo Biotechnologies raised over time?

    Censo Biotechnologies has raised $4.68M.

  • Who are Censo Biotechnologies’s investors?

    Ironbridge Capital Partners, Meltwind Advisory, and Scottish Enterprise have invested in Censo Biotechnologies.

  • When was Censo Biotechnologies acquired?

    Censo Biotechnologies was acquired on 17-Mar-2021.

  • Who acquired Censo Biotechnologies?

    Censo Biotechnologies was acquired by Axol Bioscience.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process